Relmada Therapeutics
RLMD · NASDAQ
$3.36+$0.20 (+6.33%)TodayMarket closed ·
Prev close $3.16
Who owns RLMD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 55.0% of RLMD’s shares.
- Janus Henderson Investors10.6%
- Squadron Capital Management LLC7.0%
- BlackRock Institutional Trust Company, N.A.6.6%
- VR Adviser, LLC6.5%
- Next 6 largest institutions24.2%
- All other shareholders45.0%
| Holder | Shares | % of shares |
|---|---|---|
| Janus Henderson Investors | 11.16M | 10.64% |
| Squadron Capital Management LLC | 7.35M | 7.01% |
| BlackRock Institutional Trust Company, N.A. | 6.88M | 6.56% |
| VR Adviser, LLC | 6.84M | 6.53% |
| Spruce Street Capital LP | 6.39M | 6.09% |
| Adage Capital Management, L.P. | 4.76M | 4.54% |
| Vanguard Capital Management, LLC | 4.46M | 4.25% |
| Jones Hill Capital LP | 3.66M | 3.48% |
| OrbiMed Advisors, LLC | 3.63M | 3.46% |
| State Street Investment Management (US) | 2.52M | 2.40% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.17M | 3.02% |
| iShares Russell 2000 ETF | 2.42M | 2.31% |
| Biotech Growth Trust PLC | 1.49M | 1.42% |
| Franklin Templeton Investment Funds -Biotechnology Discovery | 1.46M | 1.39% |
| Polar Capital Biotechnology Fund | 1.27M | 1.21% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $1.67M (4 trades) of RLMD on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Shenouda Maged | Buy | 79.80K | $339.15K |
| TRAVERSA SERGIO | Buy | 100.00K | $410.00K |
| Shenouda Maged | Buy | 120.20K | $504.84K |
| TRAVERSA SERGIO | Buy | 100.00K | $418.00K |
Short interest
Settled Sep 30, 2026
- Shares short
- 13.42M
- Days to cover
- 12.99
- % of shares outstanding
- 12.80%
- Average daily volume
- 1.03M
- Change since last report
- −7.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.